Exhale

The official blog of the Lung Institute.

Lung Disease in the Mountains

22 May 2015
| Under COPD, Lung Disease | Posted by
| 2 Comments

High Altitudes can be Risky for Those with COPD

For those already suffering from debilitating lung diseases like chronic obstructive pulmonary disease (COPD), the lack of oxygen in high altitude areas can be extremely dangerous. A study published by the Journal of Epidemiology and Community Health found that “Even modestly lower oxygen levels in people with already impaired breathing and gas exchange may exacerbate hypoxia and pulmonary hypertension [leading to death].” Because of this, COPD sufferers who live at higher altitudes need to take precautions such as using supplemental oxygen.

Symptoms of low oxygen levels include: shortness of breath, irritability, morning headaches or ankle swelling. Using supplemental oxygen will help prevent your heart from overworking. One particularly significant benefit of using supplemental oxygen is that it reduces a person’s shortness of breath, therefore alleviating the tiredness that comes from just walking around or exercising. Living in a high altitude area with lung disease can be very difficult for someone with COPD – but supplemental oxygen can help.

Many who previously lived at high altitudes with COPD have decided to move to areas closer to sea level where there is more oxygen in the air. Some sufferers who need supplemental oxygen at higher altitude levels have been able to significantly reduce the supplemental oxygen use at lower altitude levels. Obviously this has a significant impact on quality of life for that person.

Monitoring is Key when at High Altitudes

If you decide to live at an area with higher altitude levels, it is important to constantly monitor blood oxygen levels, or blood oxygen saturation, so that you know if you need to use supplemental oxygen. Supplemental oxygen is generally recommended when blood oxygen saturation levels drop below 90 percent.

A press release from the University of Colorado Denver reported that, in a study conducted by professors from the School of Medicine’s Altitude Research Center, University of Colorado and Harvard School of Global Health, generally those living in areas with higher altitude levels have a longer life expectancy than those living at lower levels. However, some socio-economic factors, including, among other things, pulmonary disease, completely eliminate any benefits of living at high altitude levels. While many prefer to live in areas of higher altitude levels, there are no health benefits for those living with lung disease. The key to living a healthy, stress-free life at a high altitude is constant monitoring and symptom management.

In all actuality, living in an area with high altitude predisposes lung disease sufferers ages 65-68 for a higher mortality rate or heart failure, as reported by the European Respiratory Journal. Because of this, it is generally recommended that those with pulmonary disorders avoid living in places with high altitude.

Alternative Options for those with COPD

Life can be difficult when living with a lung disease like COPD. If you must be in an area with high altitude, constant monitoring and supplemental oxygen are instrumental for maintaining a healthy lifestyle. Some patients have also seen an increased quality of life after undergoing cellular therapy. If you or a loved one is suffering from a lung disease, contact us today at 888-745-6697 to see if you qualify.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.